These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8504280)
1. Determination of the target volume of HeLa cells treated with platinum-195m radiolabeled trans-diaminedichloroplatinum(II): a comparison with cis-diaminedichloroplatinum(II). Akaboshi M; Kawai K; Maki H; Akuta K; Ujeno Y; Ono K; Miyahara T Nucl Med Biol; 1993 May; 20(4):389-93. PubMed ID: 8504280 [TBL] [Abstract][Full Text] [Related]
2. The number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration. Akaboshi M; Kawai K; Maki H; Akuta K; Ujeno Y; Miyahara T Jpn J Cancer Res; 1992 May; 83(5):522-6. PubMed ID: 1618702 [TBL] [Abstract][Full Text] [Related]
3. Cell-killing efficiency and number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with combinations of trans-diaminedichloroplatinum(II) and hyperthermia. Akaboshi M; Kawai K; Kinashi Y; Masunaga S; Ono K Jpn J Cancer Res; 1997 May; 88(5):506-11. PubMed ID: 9247608 [TBL] [Abstract][Full Text] [Related]
4. Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichloroplatinum(II). Akaboshi M; Tanaka Y; Kawai K; Akuta K; Masunaga S; Ono K Int J Radiat Biol; 1994 Aug; 66(2):215-20. PubMed ID: 8089631 [TBL] [Abstract][Full Text] [Related]
5. Determination of the target volume of HeLa cells treated with platinum-195 m radiolabeled cis-diammine(1, 1-cyclobutane-dicarboxylato)-platinum(II); comparison with cis- and trans-diamminedichloroplatinums(II). Akaboshi M; Kawai K; Tanaka Y; Sumino T; Masunaga S; Ono K; Miyahara T Nucl Med Biol; 1994 Oct; 21(7):953-8. PubMed ID: 9234349 [TBL] [Abstract][Full Text] [Related]
6. Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platin um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: comparison with cis- and trans-diamminedichloroplatinums(II). Akaboshi M; Kawai K; Ujeno Y; Takada S; Miyahara T Jpn J Cancer Res; 1994 Jan; 85(1):106-11. PubMed ID: 7508903 [TBL] [Abstract][Full Text] [Related]
7. Relationship between cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules in HeLa cells treated with cis-diamine(glycolato)platinum(II). Akaboshi M; Kawai K; Kinashi Y; Masunaga S; Ono K Jpn J Cancer Res; 1996 Feb; 87(2):178-83. PubMed ID: 8609067 [TBL] [Abstract][Full Text] [Related]
8. Cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules of HeLa cells treated with combinations of hyperthermia and cis-diamine(glycolato)platinum(II). Akaboshi M; Kawai K; Tanaka Y; Takada J; Fujii N Biol Trace Elem Res; 1999; 71-72():585-93. PubMed ID: 10676535 [TBL] [Abstract][Full Text] [Related]
9. Resistance to 195mPt-radiolabeled cis-diaminedichloroplatinum (II) of SHOK cells transfected with various oncogenes. Kinashi Y; Akaboshi M; Masunaga S; Ono K; Watanabe M Radiat Med; 1998; 16(4):233-7. PubMed ID: 9814416 [TBL] [Abstract][Full Text] [Related]
10. Interactions between mammalian cell DNA and inorganic platinum compounds. II. Interstrand cross-linking of isolated and cellular DNA by platinum(IV) compounds. Pascoe JM; Roberts JJ Biochem Pharmacol; 1974 May; 23(9):1345-57. PubMed ID: 4831343 [No Abstract] [Full Text] [Related]
12. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells. O'Neill CF; Hunakova L; Kelland LR Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899 [TBL] [Abstract][Full Text] [Related]
13. Combined effect of trans-diamminedichloroplatinum(II) and hyperthermia on murine and human tumor cells. Murthy MS; Travis JD; Erickson LC; Khandekar JD; Scanlon EF Cancer Res; 1985 Dec; 45(12 Pt 1):6232-7. PubMed ID: 4063974 [TBL] [Abstract][Full Text] [Related]
14. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts. Roberts JJ; Friedlos F Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217 [TBL] [Abstract][Full Text] [Related]
15. Transplatin, a cisplatin trans-isomer, may enhance the anticancer effect of 5-fluorouracil. Nakata B; Yamagata S; Kanehara I; Shirasaka T; Hirakawa K J Exp Clin Cancer Res; 2006 Jun; 25(2):195-200. PubMed ID: 16918130 [TBL] [Abstract][Full Text] [Related]
16. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y; Khokhar AR; al-Baker S; Siddik ZH Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629 [TBL] [Abstract][Full Text] [Related]
17. In vitro toxicity of (191)Pt-labeled cisplatin to a human cervical carcinoma cell line (ME-180). Areberg J; Johnsson A; Wennerberg J Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1275-80. PubMed ID: 10725641 [TBL] [Abstract][Full Text] [Related]
18. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo. Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001 [TBL] [Abstract][Full Text] [Related]
19. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II). Masuda H; Tanaka T; Matsuda H; Kusaba I Cancer Res; 1990 Mar; 50(6):1863-6. PubMed ID: 2306738 [TBL] [Abstract][Full Text] [Related]
20. Dose and time effects of cis-diamminedichloroplatinum(II) and radiation on mouse duodenal crypts. Dewit L; Oussoren Y; Bartelink H Radiother Oncol; 1985 Dec; 4(4):363-71. PubMed ID: 4081125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]